Intelligene Inc. (TPEX: 7832)
Health Care · Biotechnology · TW
NT$14.00
+2.56% today · +31.5% 1Y
Intelligene Inc. (TPEX: 7832) operates in the Biotechnology industry within the Health Care sector. The company is valued at $253.95M.
Over the last twelve months the share price has gained 31.5%, trading between 9.55 and 17.65.
Tweenvest scores Intelligene Inc. across four factors: quality 51/100, value 80/100. Its strongest factor is value.
7832 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $253.95M
- Revenue (TTM)
- $25.02K
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$17.65
- 52-week low
- NT$9.55
- Avg volume (3M)
- —
- Shares outstanding
- 580.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Upstream Bio, Inc.NasdaqGS: UPB | $257.42M | $4.70 | -6.75% |
| PharmaEngine, Inc.TPEX: 4162 | $257.02M | NT$57.20 | +3.25% |
| Immuneering CorporationNasdaqGM: IMRX | $254.91M | $3.94 | -3.19% |
| Amarin Corporation plcNasdaqCM: AMRN | $254.11M | $12.03 | -2.59% |
| Vicore Pharma Holding AB (publ)OM: VICO | $253.39M | Skr9.00 | -3.43% |
| Adimmune CorporationTWSE: 4142 | $253.10M | NT$19.20 | +6.67% |
| Lineage Cell Therapeutics, Inc.NYSEAM: LCTX | $251.39M | $0.99 | +6.85% |
| TriSalus Life Sciences, Inc.NasdaqGM: TLSI | $249.99M | $4.06 | -6.02% |
Figures last refreshed Oct 11, 2026.